US Exchange Filings

Mentari Therapeutics Appoints Deloitte as Auditor Following Merger

Mentari Therapeutics has replaced both predecessor auditors with Deloitte following its merger with InMed, aligning its audit oversight with the combined company’s structure. Investors should note that both former auditors had warned of substantial doubt about their respective companies’ ability to continue as going concerns.

Mentari Therapeutics has completed its post-merger change in auditors, dismissing the accounting firms that previously audited each side of the combination and appointing Deloitte & Touche to audit the company for 2026. The transition follows the Nov. 6 business combination between Mentari and InMed Pharmaceuticals, which now operates under the Mentari Therapeutics name.

For accounting purposes, the merger was treated as a reverse recapitalization, with Mentari considered the accounting acquirer. Mentari’s historical financial statements therefore became the company’s historical financial statements.

Key details

  • Both predecessor auditors were dismissed on Nov. 17. CBIZ CPAs, which audited InMed, and Ernst & Young, which audited Mentari, were removed from their respective roles. The audit committee approved both decisions.
  • Deloitte was appointed on Nov. 19 as the company’s independent auditor for the fiscal year ending Dec. 31, 2026. The audit committee approved the appointment.
  • The previous audit opinions were not adverse or qualified. CBIZ’s reports on InMed’s 2025 and 2026 fiscal-year financial statements, and EY’s report on Mentari’s financial statements for its period from inception through Dec. 31, 2025, each included a warning about substantial doubt over the relevant company’s ability to continue as a going concern. Apart from those warnings, the reports were not modified for accounting, audit-scope or other uncertainties.
  • The company reported no accounting or audit disputes with either former auditor during the periods covered, and no other reportable events. It also said neither Deloitte nor its staff had previously provided advice that influenced an accounting or auditing decision, or been consulted about a matter involving a disagreement or reportable event.

What changes

The auditor change aligns the company’s audit arrangements with its post-merger structure and with Mentari’s status as the accounting acquirer. The historical going-concern warnings remain relevant context: they applied to the predecessor companies’ financial statements, but the announcement does not provide an updated assessment of the combined company’s financial position.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.